NASDAQ · STOCK

Becton Dickinson

BDX Health Care Unknown Updated July 07, 2026
$150.40
52W $127.59 – $187.35
71/100
$41.49B
36.9
0.21
Price History (6M)
AI Committee Verdict
Buy
Conviction: High · 80% agreement · 5 analysts
+29.7%
100%
Executive Summary
5 analysts weighed in with 60% agreement on a neutral lean. Macro Analyst: Market regime is bullish (Bull market -- normal position sizing). Overall recommendation: WATCH.
Executive Summary
5 analysts weighed in with 60% agreement on a neutral lean. Macro Analyst: Market regime is bullish (Bull market -- normal position sizing). Overall recommendation: WATCH.
Bull & Bear Case
Bull Case
  • Positive MACD histogram signals bullish momentum.
  • Daily volatility (ATR%) above ~3% is treated as elevated risk.
Bear Case
  • Both daily and weekly trends are bearish — strong multi-timeframe downtrend.
  • Lower Highs / Lower Lows structure confirms bearish price action.
AI Investment Committee
Committee Consensus As of July 07, 2026
Overall Committee Score
71/100
Agreement
80%
Analysts
5
Conviction
High
Value Analyst neutral
42 / 100 · Moderate confidence
Fair value -- neither a bargain nor obviously overpriced
+ Dividend yield of 2.8% pays you to wait
− P/E of 36.9 is moderate-to-rich
Growth Analyst neutral
48 / 100 · High confidence
Moderate growth -- present but not remarkable
+ Quarter-over-quarter growth rate is ACCELERATING, not just positive
− EPS declining -24.8% YoY despite any revenue growth
Technical Analyst neutral
58 / 100 · High confidence
Mixed or range-bound price action
+ MACD histogram positive -- bullish momentum
Macro Analyst bullish
70 / 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ Market regime is bullish (Bull market -- normal position sizing)
News Analyst bullish
67 / 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.29 across 14 articles, 14d)
Open Full Terminal →
Technical Analysis
RSI (14)
46.7
Neutral
MACD Histogram
0.662
Bullish Momentum
Trend Direction
Sideways
Weekly: Downtrend
Market Structure
Lh Ll
Bollinger %B
0.55
Inside Bands
Price vs Moving Averages
EMA 9
$152.89 Below
EMA 21
$150.75 Below
EMA 50
$151.18 Below
EMA 200
$169.40 Below
Fundamental Analysis
Valuation
52
Growth
41
Profitability
34
Financial Health
57
Valuation
P/E Ratio 36.9×
P/B Ratio 2.10×
PEG Ratio
Dividend Yield 2.69%
52W High $187.35
52W Low $127.59
Quality & Growth
ROE 454.0%
ROA 211.0%
Gross Margin 4699.0%
Operating Margin 1023.0%
Revenue Growth YoY +239.0%
Debt / Equity 0.76
AI Fundamental Assessment
P/E ratio of 36.9 (rich relative to a 15-40x range); Price-to-book of 2.1x; Revenue growth (YoY) of 2.4%; EPS growth (YoY) of -24.8%; Return on equity of 4.5%; Return on assets of 2.1%; Net margin of 5.3%; Gross margin of 47.0%; Current ratio of 1.11 (tight short-term liquidity); Debt-to-equity of 0.76; Most recent quarter beat estimates by 3.5%; 2 consecutive earnings beats; EPS growth accelerating (-26.5% -> -0.3% QoQ); Analyst estimates falling over recent quarters
Key Risks
  • Both daily and weekly trends are bearish — strong multi-timeframe downtrend.
  • Lower Highs / Lower Lows structure confirms bearish price action.
This risk summary is generated from quantitative data signals, not qualitative opinion. All investors should conduct their own due diligence. This is not financial advice.
Get the Full BDX Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal → Mobile